Litigation Details for FDIC as Receiver for Signature Bridge Bank v. Concordia (S.D.N.Y. 2023)
✉ Email this page to a colleague
FDIC as Receiver for Signature Bridge Bank v. Concordia (S.D.N.Y. 2023)
| Docket | ⤷ Try a Trial | Date Filed | 2023-08-15 |
| Court | District Court, S.D. New York | Date Terminated | |
| Cause | 12:1819 FDIC: Corporate Powers | Assigned To | Laura Taylor Swain |
| Jury Demand | Plaintiff | Referred To | Gabriel W. Gorenstein |
| Patents | 6,329,404 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in FDIC as Receiver for Signature Bridge Bank v. Concordia
The small molecule drugs covered by the patent cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for FDIC as Receiver for Signature Bridge Bank v. Concordia (S.D.N.Y. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-10-24 | 21 | Affidavit of Catherine Pastrikos Kelly in Opposition to Motion to Dismiss | ACTOS (“584 patent”) and 6,329,404 (“404 patent”). The 584 and 404 drug product, “no ANDA filer would…to 404 patents and the method of use patents. Id. ¶ 144. Takeda's patents and to stay out…certification for those patents, i.e. fraudulently in obtaining a patent necessarily knows its patent either:…79,309 Where there are no applicable patents, or the patents have Generic manufacturers challenging…] on the ground that the patent does not covered by the brand's patents. See § 355(j) (2)(A) (viii | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
